If you think that the U.S. House and Senate are on two totally different paths on spending, taxes and deficit management, they don’t even come close to the vastly different paths that the FDA and the European Union are taking. It appears that the EU has decided that diabetes is a real epidemic and is willing to approve medications and devices to address this problem which is just the opposite of what our FDA appears to be doing.
Over the past months the EU has approved the Medtronic MiniMed external physiological insulin delivery (ePID) system, the Animas Vibe (combining their pump with a Dexcom CGM), Bydureon was approved last month, and now VeraLight, Inc. has received CE mark approval to sell Scout DS. The new-generation, noninvasive diabetes screening test employs fluorescence spectroscopy to scan patients’ forearms in 60 seconds for advanced glycation end products. One wonders if the FDA will adopt the same attitude.
This week Sheri Colberg, PhD shares her feelings on how often our patients get frustrated when they don’t appear to be losing weight. This week’s feature, Don’t Let Your Scale Weight Get You Down, is a must read and a great handout for your patients.
New CE! For all of you who have been waiting for new Continuing Education opportunities, we are very pleased to announce a new partnership with CardioCareLive. Check out their latest courses in our new Cardiology specialty section.
Topics: One amazing type 1 woman shares her journey around the globe to conquer television’s Amazing Race. Also, one man’s journey to better control with insulin, and Jim Turner asks what you hate about diabetes. Special Guests: Dr. Nat Strand. Sundays on CNBC at 7 PM ET, 6 PM CT, and 4 PM PT. Catch up on dLife.com.
Please answer this week’s poll: Are you willing to pay out of pocket for all future CE/CME to avoid any possible industry influence?
Check out this week’s “Test Your Diabetes Knowledge” question!
Dave Joffe, Editor-in-chief